MESSEMER DEBORAH M. 4
4 · Allogene Therapeutics, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
MESSEMER DEBORAH M.
Director
Transactions
- Award
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total→ Common Stock (95,400 underlying)
Footnotes (1)
- [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.